China Resources Medical Holdings Company Limited (1515.HK)

China Resources Medical Holdings Company Limited (1515.HK) — VMCI valuation read

Composite valuation read on 1515.HK: VMCI 62/100 against a Healthcare sector median of 50. The 12-point above-median print is the headline number for China Resources Medical Holdings Company Limited, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 1515.HK: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 1515.HK: 1515.HK trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp; net debt to EBITDA of -0.1x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

1515.HK fell 3.8% over the trailing 7 days, with a -21.8% read on a 30-day basis.